Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018
- 1 December 2018
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 272, 63-68
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Long-term Effect of Vasodilator Therapy in Pulmonary Hypertension due to COPD: A Retrospective AnalysisLung, 2014
- Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trialThe Lancet Respiratory Medicine, 2014
- Combined pulmonary fibrosis and emphysema syndrome in connective tissue diseaseArthritis & Rheumatism, 2010
- Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trialThe Lancet, 2002
- Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Predictive Factors of Hospitalization for Acute Exacerbation in a Series of 64 Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Prognostic Factors in COPD Patients Receiving Long-term Oxygen TherapyChest, 1995
- Does right ventricular function predict survival in patients with chronic obstructive lung disease?Thorax, 1988
- Patterns of Cardiovascular Dysfunction in Chronic Obstructive Lung DiseaseNew England Journal of Medicine, 1972
- Use of the Phlebomanometer: Normal venous pressure values and a study of certain clinical aspects of venous hypertension in manAmerican Heart Journal, 1946